{"id":6954,"date":"2005-12-13T15:21:34","date_gmt":"2005-12-13T14:21:34","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=6954"},"modified":"2019-01-10T15:46:50","modified_gmt":"2019-01-10T15:46:50","slug":"us-pregnancy-guidelines-updated-2","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/6954","title":{"rendered":"US pregnancy guidelines updated (Dec 2005)"},"content":{"rendered":"<p><strong>The \u0093Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States\u0094 have been revised to include:<\/strong><\/p>\n<ul>\n<li>Updates to Clinical Scenario #3. The new information discusses a 3 to 7 day \u0093tail\u0094 of postpartum maternal ZDV\/3TC following single dose maternal\/infant nevirapine; this \u0093tail\u0094 may reduce the risk of nevirapine resistance.<\/li>\n<li>Updated information on the role of cesarean delivery in preventing mother-to-child transmission of HIV.<\/li>\n<li>An updated Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy, including a new section on tipranavir.<\/li>\n<li>A Perinatal Antiretroviral Guidelines Working Group Conflict of Interest Disclosure (Appendix).<\/li>\n<\/ul>\n<p>Updated information appears highlighted in yellow.<\/p>\n<p>You can download the updated guidelines, or request to receive them by e-mail or hard copy from the AIDSinfo Web site:<\/p>\n<p>AIDSinfo &#8211; HIV \/ Medical Practice Guidelines<br \/>\n<a href=\"http:\/\/www.aidsinfo.nih.gov\/guidelines\">http:\/\/www.aidsinfo.nih.gov\/guidelines<\/a><\/p>\n<p>The AIDSinfo website is also a useful source of other information related to HIV\/AIDS, including other treatment and prevention guidelines, downloadable databases for PDAs (Personal Digital Assistants), fact sheets, and HIV\/AIDS-related clinical trials information.<\/p>\n<p>Source: FDA list serve<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The \u0093Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States\u0094 have been revised to include: Updates to Clinical Scenario #3. &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35,23],"tags":[],"class_list":["post-6954","post","type-post","status-publish","format-standard","hentry","category-pmtct-and-maternal-health","category-guidelines"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=6954"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6954\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=6954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=6954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=6954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}